Evaluation of SARS-CoV‑2 Main Protease Inhibitors Using a Novel Cell-Based Assay
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Chemical Society
2022-02-01
|
| Series: | ACS Central Science |
| Online Access: | https://doi.org/10.1021/acscentsci.1c00910 |
| _version_ | 1818330841036619776 |
|---|---|
| author | Wenyue Cao Chia-Chuan Dean Cho Zhi Zachary Geng Namir Shaabani Xinyu R. Ma Erol C. Vatansever Yugendar R. Alugubelli Yuying Ma Sankar P. Chaki William H. Ellenburg Kai S. Yang Yuchen Qiao Robert Allen Benjamin W. Neuman Henry Ji Shiqing Xu Wenshe Ray Liu |
| author_facet | Wenyue Cao Chia-Chuan Dean Cho Zhi Zachary Geng Namir Shaabani Xinyu R. Ma Erol C. Vatansever Yugendar R. Alugubelli Yuying Ma Sankar P. Chaki William H. Ellenburg Kai S. Yang Yuchen Qiao Robert Allen Benjamin W. Neuman Henry Ji Shiqing Xu Wenshe Ray Liu |
| author_sort | Wenyue Cao |
| collection | DOAJ |
| first_indexed | 2024-12-13T13:10:21Z |
| format | Article |
| id | doaj.art-f8e6bc3a68de4550a1f279b547e4da04 |
| institution | Directory Open Access Journal |
| issn | 2374-7951 |
| language | English |
| last_indexed | 2024-12-13T13:10:21Z |
| publishDate | 2022-02-01 |
| publisher | American Chemical Society |
| record_format | Article |
| series | ACS Central Science |
| spelling | doaj.art-f8e6bc3a68de4550a1f279b547e4da042022-12-21T23:44:42ZengAmerican Chemical SocietyACS Central Science2374-79512022-02-018219220410.1021/acscentsci.1c00910Evaluation of SARS-CoV‑2 Main Protease Inhibitors Using a Novel Cell-Based AssayWenyue Cao0Chia-Chuan Dean Cho1Zhi Zachary Geng2Namir Shaabani3Xinyu R. Ma4Erol C. Vatansever5Yugendar R. Alugubelli6Yuying Ma7Sankar P. Chaki8William H. Ellenburg9Kai S. Yang10Yuchen Qiao11Robert Allen12Benjamin W. Neuman13Henry Ji14Shiqing Xu15Wenshe Ray Liu16Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United StatesTexas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United StatesTexas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United StatesSorrento Therapeutics, Inc., San Diego, California, United StatesTexas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United StatesTexas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United StatesTexas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United StatesTexas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United StatesGlobal Health Research Complex, Division of Research, Texas A&M University, College Station, Texas, United StatesTexas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United StatesTexas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United StatesTexas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United StatesSorrento Therapeutics, Inc., San Diego, California, United StatesDepartment of Biology, Texas A&M University, College Station, Texas, United StatesSorrento Therapeutics, Inc., San Diego, California, United StatesTexas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United StatesTexas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United Stateshttps://doi.org/10.1021/acscentsci.1c00910 |
| spellingShingle | Wenyue Cao Chia-Chuan Dean Cho Zhi Zachary Geng Namir Shaabani Xinyu R. Ma Erol C. Vatansever Yugendar R. Alugubelli Yuying Ma Sankar P. Chaki William H. Ellenburg Kai S. Yang Yuchen Qiao Robert Allen Benjamin W. Neuman Henry Ji Shiqing Xu Wenshe Ray Liu Evaluation of SARS-CoV‑2 Main Protease Inhibitors Using a Novel Cell-Based Assay ACS Central Science |
| title | Evaluation of SARS-CoV‑2 Main Protease Inhibitors Using a Novel Cell-Based Assay |
| title_full | Evaluation of SARS-CoV‑2 Main Protease Inhibitors Using a Novel Cell-Based Assay |
| title_fullStr | Evaluation of SARS-CoV‑2 Main Protease Inhibitors Using a Novel Cell-Based Assay |
| title_full_unstemmed | Evaluation of SARS-CoV‑2 Main Protease Inhibitors Using a Novel Cell-Based Assay |
| title_short | Evaluation of SARS-CoV‑2 Main Protease Inhibitors Using a Novel Cell-Based Assay |
| title_sort | evaluation of sars cov 2 main protease inhibitors using a novel cell based assay |
| url | https://doi.org/10.1021/acscentsci.1c00910 |
| work_keys_str_mv | AT wenyuecao evaluationofsarscov2mainproteaseinhibitorsusinganovelcellbasedassay AT chiachuandeancho evaluationofsarscov2mainproteaseinhibitorsusinganovelcellbasedassay AT zhizacharygeng evaluationofsarscov2mainproteaseinhibitorsusinganovelcellbasedassay AT namirshaabani evaluationofsarscov2mainproteaseinhibitorsusinganovelcellbasedassay AT xinyurma evaluationofsarscov2mainproteaseinhibitorsusinganovelcellbasedassay AT erolcvatansever evaluationofsarscov2mainproteaseinhibitorsusinganovelcellbasedassay AT yugendarralugubelli evaluationofsarscov2mainproteaseinhibitorsusinganovelcellbasedassay AT yuyingma evaluationofsarscov2mainproteaseinhibitorsusinganovelcellbasedassay AT sankarpchaki evaluationofsarscov2mainproteaseinhibitorsusinganovelcellbasedassay AT williamhellenburg evaluationofsarscov2mainproteaseinhibitorsusinganovelcellbasedassay AT kaisyang evaluationofsarscov2mainproteaseinhibitorsusinganovelcellbasedassay AT yuchenqiao evaluationofsarscov2mainproteaseinhibitorsusinganovelcellbasedassay AT robertallen evaluationofsarscov2mainproteaseinhibitorsusinganovelcellbasedassay AT benjaminwneuman evaluationofsarscov2mainproteaseinhibitorsusinganovelcellbasedassay AT henryji evaluationofsarscov2mainproteaseinhibitorsusinganovelcellbasedassay AT shiqingxu evaluationofsarscov2mainproteaseinhibitorsusinganovelcellbasedassay AT wensherayliu evaluationofsarscov2mainproteaseinhibitorsusinganovelcellbasedassay |